GlassScriptPhysician profile
Michael W Wong
NPI 1184002537
$13,719.54
in general payments reported to CMS, 2019-2025
42 companies · $3,638 in 2025
The $3,638 reported for 2025 was more than what 97% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.61 · 2020: $728 · 2021: $1,120 · 2022: $1,697 · 2023: $2,367 · 2024: $4,154 · 2025: $3,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,435 · Travel and Lodging: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,435.09 |
| Travel and Lodging | $723.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,100.58 | 2020-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $1,476.27 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $1,399.73 | 2020-2025 | Spravato, Xarelto |
| Abbvie INC. | $1,037.94 | 2021-2025 | Qulipta, Ubrelvy |
| Boston Scientific Corporation | $1,032.25 | 2024 | Intracept |
| Phathom Pharmaceuticals, INC. | $988.00 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $850.78 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Bioventus LLC | $836.00 | 2020-2025 | Durolane, Xcell, Exogen Ultrasound Bone Healing System |
| Glaxosmithkline, LLC. | $491.03 | 2021-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Amgen INC. | $401.77 | 2020-2025 | Otezla, Repatha, Prolia |
| E.R. Squibb & Sons, L.L.C. | $358.95 | 2021-2024 | Eliquis |
| Exact Sciences Corporation | $341.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $321.69 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $250.91 | 2023-2025 | Zilretta, Iovera |
| Edwards Lifesciences Corporation | $170.95 | 2024 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.